Pharmaceutical Goods Price in Kazakhstan - 2021

Pharmaceutical Goods Price in Kazakhstan (CIF) - 2022

The average pharmaceutical goods import price stood at $119,063 per ton in 2022, rising by 19% against the previous year. In general, the import price, however, saw a relatively flat trend pattern. Over the period under review, average import prices hit record highs at $152,847 per ton in 2014; however, from 2015 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($328,361 per ton), while the price for China ($14,798 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Russia (+2.7%), while the prices for the other major suppliers experienced more modest paces of growth.

Pharmaceutical Goods Price in Kazakhstan (FOB) - 2022

The average pharmaceutical goods export price stood at $41,530 per ton in 2022, shrinking by -41% against the previous year. Overall, the export price saw a deep downturn. The most prominent rate of growth was recorded in 2019 when the average export price increased by 52% against the previous year. Over the period under review, the average export prices reached the maximum at $219,366 per ton in 2017; however, from 2018 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Kyrgyzstan ($66,973 per ton), while the average price for exports to Russia totaled $35,511 per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Afghanistan (+29.7%), while the prices for the other major destinations experienced more modest paces of growth.

Pharmaceutical Goods Imports in Kazakhstan

Pharmaceutical goods imports into Kazakhstan declined to 353 tons in 2022, shrinking by -6.4% against the previous year. The total import volume increased at an average annual rate of +1.3% from 2019 to 2022; the trend pattern remained relatively stable, with only minor fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2021 with an increase of 15%. As a result, imports attained the peak of 377 tons, and then fell in the following year.

In value terms, pharmaceutical goods imports expanded significantly to $42M in 2022. The total import value increased at an average annual rate of +11.3% from 2019 to 2022; the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2021 with an increase of 13%. Over the period under review, imports hit record highs in 2022 and are likely to continue growth in the near future.

Import of Pharmaceutical Goods in Kazakhstan (Million USD)
COUNTRY	2019	2020	2021	2022	CAGR, 2019-2022
Germany	7.8	9.9	11.7	11.5	13.8%
Hungary	1.4	3.8	4.8	7.2	72.6%
United States	2.2	1.1	2.6	3.6	17.8%
Russia	7.8	5.5	6.4	3.4	-24.2%
South Korea	1.0	1.0	1.3	2.5	35.7%
Ireland	0.8	0.5	1.9	1.9	33.4%
Switzerland	1.7	1.5	2.0	1.8	1.9%
India	0.6	0.8	0.4	0.4	-12.6%
Ukraine	0.2	N/A	0.1	0.3	14.5%
China	0.2	0.2	0.3	0.3	14.5%
Others	6.9	9.2	6.2	9.0	9.3%
Total	30.5	33.4	37.7	42.0	11.3%

Top Suppliers of Pharmaceutical Goods to Kazakhstan in 2022:

Russia (153.4 tons)
Germany (67.7 tons)
Hungary (23.6 tons)
China (21.9 tons)
South Korea (13.2 tons)
Ireland (12.0 tons)
United States (11.0 tons)
India (9.3 tons)
Switzerland (9.2 tons)
Ukraine (6.7 tons)

Pharmaceutical Goods Exports in Kazakhstan

In 2022, pharmaceutical goods exports from Kazakhstan skyrocketed to 19 tons, jumping by 1,043% compared with 2021. Overall, exports showed a significant expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, pharmaceutical goods exports surged to $785K in 2022. Over the period under review, exports saw significant growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.